Xi (Cynthia) S. is a Senior Medical Director at Syndax Pharmaceuticals since 2023. Previously, Xi served as the Associate Medical Director for Global Patient Safety at BeiGene from 2019 to 2021 and held various roles in drug safety and medical affairs at organizations such as Mesoblast Limited and SpringWorks Therapeutics. They began their career as a Senior Scientist at Pfizer from 2008 to 2018. Xi is currently pursuing degrees in Clinical Trial Management at Temple University School of Pharmacy, as well as an MD from Peking Union Medical College, while having completed pre-med studies at Peking University.
This person is not in any teams
This person is not in any offices